Peripheral vascular disease (PVD) involves shrinking of arteries outside heart and brain. PVD can be caused due to obesity, smoking, hypertension, and diabetes. The blocked arteries are treated using peripheral vascular devices to remove the plaque build-up. The commonly used devices for the treatment of PVD include peripheral transluminal angioplasty balloon catheter, peripheral vascular stents, and aortic stents.
Get FREE Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/391
The global peripheral vascular devices market was valued at US$ 8,319.0 Mn in 2019 and is forecast to reach a value of US$ 14,592.7 Mn by 2027 at a CAGR of 7.3% between 2020 and 2027.
Rising old age population is expected to propel growth of the global peripheral vascular devices. For instance, the World Health Organization reported that geriatric population is projected to increase from 900 million in 2015 to 2 billion by 2050.
Furthermore, rising cases of peripheral arterial disease is expected to boost growth of the global peripheral vascular devices market during the forecast period. For instance, in 2018, National Center for Biotechnology Information released data according to which, peripheral arterial disease affects 200 million people across the world.
Infection occurring due to peripheral vascular implantation is expected restrict growth of the global market of peripheral vascular devices market. Medical devices create risk of fungal and bacterial infection, however, foreign body insertion has become vital part of the medical field. Peripheral vascular implants cause high risk of infection as they need to be in direct contact with the body than other devices.
Furthermore, increasing product recalls are projected to hamper growth of the global peripheral vascular devices market. For instance, in October 2019, due to a risk of outer material separation from the device in fractured pieces that could be left in the bloodstream of the patient, Medtronic plc. Started the recall of all 6 French Sherpa NX Active Guide Catheter model.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/391
Increasing research and development activities in peripheral catheters is expected to create lucrative environment of opportunities for market competitors in the global market of peripheral vascular devices. For instance, in October 2019, a team of scientists from PICC Excellence and Hartford Hospital (Hartford, Conn.) demonstrated that implementation of standardized set of best practice to insert peripheral IV catheters gives substantial economical and clinical advantages.
Furthermore, rise in the number of cases of hypertension and type 2 diabetes mellitus is expected to increase demand for peripheral vascular devices. For instance, in March 2019, a study reported that hypothyroidism affects 24.8% of patients with type 2 diabetes, 28.9% patients with type 2 diabetes mellitus + hypertension, and 33.5% patients with hypertension.
Key player in the market are adopting various strategies such as approval and launch of novel devices to strengthen their portfolio of products. For instance, in 2018, the U.S. FDA granted 510(k) clearance to Teleflex Incorporated for Sympro Elite Snares and Expro Elite for manipulation of interventional devices in peripheral processes.
Growing awareness about peripheral vascular disease is expected to augment growth of the global market of peripheral vascular devices. For instance, in November 2019, MD Interventional Cardiologist of Heart of Texas Heart Associates, Ernesto Rivera, and Brownwood Regional Medical Center conducted a Community Education Program on Diabetic Foot Ulcers and Peripheral Vascular Disease.
key players active in the global peripheral vascular devices market are, Boston Scientific Corporation, Emboline Inc., Cook Group Inc., Covidien PLC, Medtronic Plc, Bayer AG, Abbot Laboratories, Angioscore, BD, Cordis Corporation, Edward Lifesciences Corporation, and St. Jude Medical.
Market players are focusing on strategies such as mergers and acquisitions to increase their portfolio of products. For instance, in June 2020, Becton, Dickinson and Company completed the acquisition of Straub Medical AG, a privately-held company that develops and sells medical atherectomy and thrombectomy devices for the treatment of venous disease and peripheral arterial disease (PAD).
𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐨 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐭𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/391
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Peripheral Vascular Devices Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Peripheral Vascular Devices Industry Impact
Chapter 2 Global Peripheral Vascular Devices Competition by Types, Applications, and Top Regions and Countries
2.1 Global Peripheral Vascular Devices (Volume and Value) by Type
2.3 Global Peripheral Vascular Devices (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Peripheral Vascular Devices Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Peripheral Vascular Devices Market Analysis
Chapter 6 East Asia Peripheral Vascular Devices Market Analysis
Chapter 7 Europe Peripheral Vascular Devices Market Analysis
Chapter 8 South Asia Peripheral Vascular Devices Market Analysis
Chapter 9 Southeast Asia Peripheral Vascular Devices Market Analysis
Chapter 10 Middle East Peripheral Vascular Devices Market Analysis
Chapter 11 Africa Peripheral Vascular Devices Market Analysis
Chapter 12 Oceania Peripheral Vascular Devices Market Analysis
Chapter 13 South America Peripheral Vascular Devices Market Analysis
Chapter 14 Company Profiles and Key Figures in Peripheral Vascular Devices Business
Chapter 15 Global Peripheral Vascular Devices Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027